Xilio Therapeutics Inc (XLO)
Aktien-Chart
Earnings
Value bought
Letzte 90 Tage
Value sold
Letzte 90 Tage
Net insiders buying
Letzte 90 Tage
Trades (buy and sell)
Letzte 90 Tage
| Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion | Insider und/oder position |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Wert | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-01-03 | 2025-01-02 | GV Geplanter Verkauf |
SVP, FINANCE AND ACCOUNTING Führungsperson |
1.803
-36.1%
0,981.774 USD |
1.803 -36.1% | 0,98 | 1.774 USD | |
| 2025-01-03 | 2025-01-02 | GV Geplanter Verkauf |
Frankenfield Christopher James Chief Financial Officer Führungsperson |
6.954
-35.9%
0,986.841 USD |
6.954 -35.9% | 0,98 | 6.841 USD | |
| 2024-12-19 | 2024-12-18 | K Kauf | Large shareholder |
1.759.978
+24.0%
1,041.830.377 USD |
1.759.978 +24.0% | 1,04 | 1.830.377 USD | |
| 2024-04-03 | 2024-04-02 | K Kauf | Large shareholder |
485.250
+7.1%
0,76368.790 USD |
485.250 +7.1% | 0,76 | 368.790 USD | |
| 2024-02-09 | 2024-02-08 | V Verkauf | Large shareholder |
267
-0.0%
0,64171 USD |
267 -0.0% | 0,64 | 171 USD | |
| 2024-02-09 | 2024-02-08 | V Verkauf | Large shareholder |
733
-0.0%
0,64469 USD |
733 -0.0% | 0,64 | 469 USD | |
| 2024-01-16 | 2024-01-12 | V Verkauf | Large shareholder |
560
-0.1%
0,83465 USD |
560 -0.1% | 0,83 | 465 USD | |
| 2024-01-16 | 2024-01-12 | V Verkauf | Large shareholder |
1.540
-0.1%
0,831.278 USD |
1.540 -0.1% | 0,83 | 1.278 USD | |
| 2024-01-16 | 2024-01-11 | V Verkauf | Large shareholder |
569
-0.1%
0,87495 USD |
569 -0.1% | 0,87 | 495 USD | |
| 2024-01-16 | 2024-01-11 | V Verkauf | Large shareholder |
1.566
-0.1%
0,871.362 USD |
1.566 -0.1% | 0,87 | 1.362 USD | |
| 2021-12-10 | 2021-12-10 | K Kauf |
Bain Capital Life Sciences Investors, LLC Large shareholder |
3.188
+0.1%
10,2432.638 USD |
3.188 +0.1% | 10,24 | 32.638 USD | |
| 2021-12-10 | 2021-12-10 | K Kauf |
Bain Capital Life Sciences Investors, LLC Large shareholder |
21.812
+0.8%
9,56208.564 USD |
21.812 +0.8% | 9,56 | 208.564 USD | |
| 2021-12-10 | 2021-12-09 | K Kauf |
Bain Capital Life Sciences Investors, LLC Large shareholder |
4.011
+0.1%
9,8439.485 USD |
4.011 +0.1% | 9,84 | 39.485 USD | |
| 2021-12-10 | 2021-12-08 | K Kauf |
Bain Capital Life Sciences Investors, LLC Large shareholder |
13.458
+0.5%
9,62129.474 USD |
13.458 +0.5% | 9,62 | 129.474 USD | |
| 2021-10-28 | 2021-10-26 | K Kauf | Large shareholder |
387.500
+51.2%
16,006.200.000 USD |
387.500 +51.2% | 16,00 | 6.200.000 USD | |
| 2021-10-28 | 2021-10-26 | K Kauf | Large shareholder |
387.500
+51.2%
16,006.200.000 USD |
387.500 +51.2% | 16,00 | 6.200.000 USD | |
| 2021-10-26 | 2021-10-26 | K Kauf | Large shareholder |
187.500
+34.2%
16,003.000.000 USD |
187.500 +34.2% | 16,00 | 3.000.000 USD | |
| 2021-10-26 | 2021-10-26 | K Kauf |
Rock Springs Capital Management LP Large shareholder |
500.000
+66.1%
16,008.000.000 USD |
500.000 +66.1% | 16,00 | 8.000.000 USD | |
| 2021-10-26 | 2021-10-26 | K Kauf | Large shareholder |
312.500
+38.3%
16,005.000.000 USD |
312.500 +38.3% | 16,00 | 5.000.000 USD | |
| 2021-10-26 | 2021-10-26 | K Kauf |
RiverVest Venture Fund IV, L.P. Large shareholder |
250.000
+21.0%
16,004.000.000 USD |
250.000 +21.0% | 16,00 | 4.000.000 USD |